Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Sullivan

Showing results (1211-1220 of 1,317) with videos related to

Pageof 132
Sort By:
Journal of Medicinal Chemistry|July 9, 2004
Discovery of 2-(4-pyridin-2-ylpiperazin-1-ylmethyl)-1H-benzimidazole (ABT-724), a dopaminergic agent with a novel mode of action for the potential treatment of erectile dysfunctionMarlon Cowart, Steven P Latshaw, Pramila Bhatia, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Structure-activity studies related to ABT-594, a potent nonopioid analgesic agent: effect of pyridine and azetidine ring substitutions on nicotinic acetylcholine receptor binding affinity and analgesic activity in miceM W Holladay, H Bai, Y Li, et al.
The Journal of Clinical Investigation|November 28, 2023
Age-related loss of Notch3 underlies brain vascular contractility deficiencies, glymphatic dysfunction, and neurodegeneration in miceMilagros C Romay, Russell H Knutsen, Feiyang Ma, et al.
Global Change Biology|January 26, 2024
Global dominance of lianas over trees is driven by forest disturbance, climate and topographyAlain Senghor K Ngute, David S Schoeman, Marion Pfeifer, et al.
Nature Communications|November 2, 2022
Gut microbiome dysbiosis in antibiotic-treated COVID-19 patients is associated with microbial translocation and bacteremiaLucie Bernard-Raichon, Mericien Venzon, Jon Klein, et al.
Biorxiv : the Preprint Server for Biology|March 9, 2022
Gut microbiome dysbiosis during COVID-19 is associated with increased risk for bacteremia and microbial translocationMericien Venzon, Lucie Bernard-Raichon, Jon Klein, et al.
European Journal of Immunology|September 9, 2024
MicroRNA-146a deficiency enhances host protection against murine cytomegalovirusPamela Wong, Jeffrey W Leong, Hyogon Sohn, et al.
Sleep|May 21, 2019
Effects on resident work hours, sleep duration, and work experience in a randomized order safety trial evaluating resident-physician schedules (ROSTERS)Laura K Barger, Jason P Sullivan, Terri Blackwell, et al.
Sleep Advances : a Journal of the Sleep Research Society|October 13, 2025
Obstructive sleep apnea diagnosis and management in First Nations communities: protocol for the Let's Yarn About Sleep-Obstructive Sleep Apnea ProgramYaqoot Fatima, Shannon L Edmed, Roslyn Von Senden, et al.
Immunity|August 13, 2019
MicroRNA-142 Is Critical for the Homeostasis and Function of Type 1 Innate Lymphoid CellsMelissa M Berrien-Elliott, Yaping Sun, Carly Neal, et al.
Pageof 132

Showing results (1211-1220 of 1,317) with videos related to

Sort By:
Pageof 132
Journal of Medicinal Chemistry|July 9, 2004
Discovery of 2-(4-pyridin-2-ylpiperazin-1-ylmethyl)-1H-benzimidazole (ABT-724), a dopaminergic agent with a novel mode of action for the potential treatment of erectile dysfunctionMarlon Cowart, Steven P Latshaw, Pramila Bhatia, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Structure-activity studies related to ABT-594, a potent nonopioid analgesic agent: effect of pyridine and azetidine ring substitutions on nicotinic acetylcholine receptor binding affinity and analgesic activity in miceM W Holladay, H Bai, Y Li, et al.
The Journal of Clinical Investigation|November 28, 2023
Age-related loss of Notch3 underlies brain vascular contractility deficiencies, glymphatic dysfunction, and neurodegeneration in miceMilagros C Romay, Russell H Knutsen, Feiyang Ma, et al.
Global Change Biology|January 26, 2024
Global dominance of lianas over trees is driven by forest disturbance, climate and topographyAlain Senghor K Ngute, David S Schoeman, Marion Pfeifer, et al.
Nature Communications|November 2, 2022
Gut microbiome dysbiosis in antibiotic-treated COVID-19 patients is associated with microbial translocation and bacteremiaLucie Bernard-Raichon, Mericien Venzon, Jon Klein, et al.
Biorxiv : the Preprint Server for Biology|March 9, 2022
Gut microbiome dysbiosis during COVID-19 is associated with increased risk for bacteremia and microbial translocationMericien Venzon, Lucie Bernard-Raichon, Jon Klein, et al.
European Journal of Immunology|September 9, 2024
MicroRNA-146a deficiency enhances host protection against murine cytomegalovirusPamela Wong, Jeffrey W Leong, Hyogon Sohn, et al.
Sleep|May 21, 2019
Effects on resident work hours, sleep duration, and work experience in a randomized order safety trial evaluating resident-physician schedules (ROSTERS)Laura K Barger, Jason P Sullivan, Terri Blackwell, et al.
Sleep Advances : a Journal of the Sleep Research Society|October 13, 2025
Obstructive sleep apnea diagnosis and management in First Nations communities: protocol for the Let's Yarn About Sleep-Obstructive Sleep Apnea ProgramYaqoot Fatima, Shannon L Edmed, Roslyn Von Senden, et al.
Immunity|August 13, 2019
MicroRNA-142 Is Critical for the Homeostasis and Function of Type 1 Innate Lymphoid CellsMelissa M Berrien-Elliott, Yaping Sun, Carly Neal, et al.
Pageof 132